Oocytes within follicles and those in the oviduct are exposed to reactive oxygen species (ROS) \[[@r1]\]. These moderate amounts of ROS are involved not only in various cellular signaling but also in cell cycles such as diplotene arrest, resumption, and metaphase II (MII) arrest in oocytes \[[@r1],[@r2],[@r3]\]. However, in the case of excessive ROS production, oxidative stress causes mitochondrial alterations, perturbed embryonic development, ATP depletion, apoptosis, and fragmentation \[[@r4], [@r5]\]. To prevent excessive accumulation of ROS in normal oocytes and embryos, various antioxidant enzymes are generally involved in controlling the ROS level \[[@r4], [@r5]\]. As a mechanism of eliminating intracellular ROS, superoxide, arising from oxygen metabolism in mitochondria, is converted to hydrogen peroxide (H~2~O~2~) by superoxide dismutase (SOD) and H~2~O~2~ is promptly eliminated by glutathione (GSH) which is catalyzed by some antioxidant enzymes such as glutathione peroxidase (GPX) \[[@r4],[@r5],[@r6],[@r7],[@r8]\]. The function of GSH as the most abundant endogenous reducer in animal cells has been demonstrated in mouse oocytes and embryos \[[@r4],[@r5],[@r6],[@r7],[@r8]\]. In fact, mice deficient in GSH synthesis die before E8.5, hence GSH is required for embryo development \[[@r9]\]. In addition to GSH, thioredoxin (TRX) is another redox protein widely preserved in various organisms, from archaea and bacteria to humans \[[@r10]\]. TRX plays a role in the maintenance of antioxidant enzymes that directly eliminate H~2~O~2~ by reducing oxidized enzymes \[[@r10]\]. TRX knockout mice are embryonic lethal around E10.5 \[[@r11]\]. In these ways, the GSH and TRX systems regulate the ROS levels in early embryos as well as cultured cells \[[@r4],[@r5],[@r6],[@r7],[@r8],[@r9],[@r10],[@r11]\].

While ovulated oocytes are protected from ROS and are maintained in the intracellular redox state by antioxidant enzymes \[[@r4], [@r5]\], ROS levels increase in zygotes immediately after fertilization \[[@r12], [@r13]\]. Indeed, various important phenomena occur in freshly fertilized oocytes, including Ca^2+^ oscillations, meiosis resumption, 2nd polar body extrusion, protamine-histone exchange, DNA demethylation on the male genome, and DNA replication \[[@r14], [@r15]\]. In the case of excessive H~2~O~2~-treatment of pronuclear-formed zygotes, DNA damage increases and cleavage is arrested \[[@r16], [@r17]\]. Although it seems to be important for adequately maintaining ROS levels in fertilized oocytes as well as ovulated oocytes, the antioxidant mechanism of endogenous proteins in freshly fertilized oocytes has not been well understood.

In this study, we explored abundant the antioxidant enzymes using mouse zygotes by proteomics analysis to uncover the antioxidant mechanisms in zygotes. As a result, peroxiredoxin 1 (PRDX1) was identified as the most abundant antioxidant enzyme in zygotes. PRDX proteins play a role of catalyzing the reduction of cellular hydrogen peroxide (H~2~O~2~) to H~2~O in the TRX/PRDX system \[[@r18]\]. Interestingly, immunocytochemical analysis showed that hyperoxidized PRDX family members including PRDX1 were localized in the male and female pronuclei of zygotes. Hyperoxidized PRDX proteins in the pronuclei of H~2~O~2~-treated zygotes at PN3 were significantly increased compared to those in untreated controls. Concurrently, 5-hydroxymethylcytosine (5hmC) was significantly decreased in the male pronuclei of zygotes. Thus, our results indicate the necessity to investigate the relationship between antioxidant enzymes and epigenetic reprogramming in further research.

Materials and Methods {#s1}
=====================

Animals
-------

All mice (ICR strain) were purchased from Kiwa Laboratory Animals (Wakayama, Japan) and maintained in light-controlled, air-conditioned rooms. This study was carried out in strict accordance with the recommendations in the Guidelines of Kindai University for the Care and Use of Laboratory Animals. Experimental protocols were approved by the Committee on the Ethics of Animal experiments of Kindai University (Permit Number: KABT-26-002). All mice were killed by cervical dislocation and all efforts were made to minimize suffering and to reduce the number of animals used in the present study.

In vitro fertilization and embryo culture
-----------------------------------------

Collection of spermatozoa, oocytes, and zygotes were performed as described in previous studies \[[@r19],[@r20],[@r21],[@r22],[@r23],[@r24],[@r25]\]. Spermatozoa were collected from the cauda epididymidis of male mice. The sperm suspension was incubated in human tubal fluid (HTF) medium for 1.5 h to allow for capacitation at 37°C under 5% CO~2~ in air. Oocytes were collected from the excised oviducts of female mice (2--3 months old) that were superovulated with pregnant mare serum gonadotropin (PMSG; Serotropin, Teikoku Zoki, Tokyo, Japan) and 48 h later, human chorionic gonadotropin (hCG; Puberogen, Sankyo, Tokyo, Japan). Cumulus-oocyte complexes were recovered into pre-equilibrated HTF medium. The sperm suspension was added to the oocyte cultures and morphologically normal zygotes were collected 2 h after insemination. The zygotes were cultured in potassium simplex optimized medium (KSOM) \[[@r26]\] at 37°C under 5% CO~2~ in air.

Two-dimensional gel electrophoresis (2-DE)
------------------------------------------

600, 10,000, and 15,000 MII oocytes for obtaining 2-DE master gels, and 600 MII oocytes and 600 zygotes for obtaining the gels for quantitative analysis of protein spots, in each case were sonicated three times at 4°C for 30 sec. The sonicated samples were resuspended in lysis buffer composed of 7 M urea, 2 M thiourea, 4% CHAPS, 0.5% immobilized pH gradient (IPG) buffer (GE Healthcare, Little Chalfont, UK), 0.05% tri-n-butylphosphine, 1 tablet per 10 ml complete mini protease inhibitor (Roche, Mannheim, Germany), and traces of bromophenol blue (BPB). The resuspended samples were precipitated with three volumes of 100% acetone and mixed with rehydration solution (7 M urea, 2 M thiourea, 4% CHAPS, 0.05% tri-n-butylphosphine, IPG buffer, and traces of BPB). The 2-DE procedure was performed as described previously \[[@r27], [@r28]\]. The obtained proteins were separated in the first dimension on immobilized pH gradient IPG gels (Immobiline DryStrip, pH 3-11 nonlinear gradient, 13 cm, GE Healthcare). IPG gels were rehydrated overnight with rehydration solution containing protein samples. First-dimension electrophoresis was performed at 15°C under the following conditions: 1 min of linear gradient from 0 to 500 V, 8 h of constant voltage at 500 V, 1.5 h of linear gradient from 500 to 3,500 V, and 5.4 h of constant voltage at 3,500 V. Strips were then washed with distilled water and equilibrated at RT for 15 min in 5 ml of equilibration buffer composed of 6 M urea, 50 mM Tris-HCl (pH 8.0), 30% glycerol, 2% SDS, 50 mg DTT, and traces of BPB before being incubated for 15 min in an equilibration solution of the same composition except for 125 mg iodoacetamide replacing the DTT. The equilibrated strips were transferred onto the SDS-PAGE gel. Second dimension electrophoresis was performed on 12% polyacrylamide gels in CoolPhoreStar SDS-PAGE Tetra-200 (Anatech, Tokyo, Japan) with a constant current of 30 mA per gel for 1 h.

Visualization and image analysis of 2-DE gels
---------------------------------------------

The gels were fixed with a fixation solution containing 10% methanol and 7% acetic acid for 30 min at room temperature (RT) and then transferred to distilled water for 20 min. The gels were stained with SYPRO Ruby (Invitrogen, Carlsbad, CA, USA) overnight and then washed with 10% ethanol. Gel images were obtained using an AlphaImager (Alpha Innotech, San Leandro, CA, USA) and analyzed using Progenesis PG220 and TT900 (Nonlinear Dynamics, Newcastle upon Tyne, UK) for spot detection, quantification, and comparative analysis.

MALDI sample preparation
------------------------

For protein identification by mass spectrometry, protein spots in the 2-DE master gels from each 600, 10,000, and 15,000 MII oocytes were collected by gloved hand on a Safe Imager blue light transilluminator (Invitrogen). Gel pieces were incubated three times in destaining solution consisting of 50% acetonitrile (ACN) in 50 mM ammonium bicarbonate for 20 min at 37°C. The gel pieces were then incubated in 100% ACN for 1 min before being dried completely. The obtained proteins were digested with 1.67 µg/ml trypsin (Promega, Southampton, UK) in 25 mM ammonium bicarbonate at 30°C overnight. The digested proteins were purified and concentrated using ZipTipTMµC18 (Millipore, Bedford, MA, USA). The peptides absorbed in the gel were directly eluted onto the MALDI sample plate using 2.5 mg/ml α-cyano-4-hydroxycinnamic acid (Waters, Milford, MA, USA) in 70% ACN containing 0.1% trifluoroacetic acid.

MALDI-TOF/MS
------------

MS spectrometric analysis of the tryptic was performed using a 4700 MALDI-TOF/TOF mass spectrometer (Applied Biosystems, Foster City, CA, USA). MS spectra were measured in the positive-ion reflector mode with a mass range from 700 to 3,500. Data were subjected to external calibration with five standard peptides (Sigma, St. Louis, MO, USA). The MS/MS spectra were measured in CID mode. From a single parent MS spectrum, the five most abundant ions were selected for MS/MS analysis. The data were subjected to external calibration using fragment peaks of the human ACTH peptide 18-39 (MH1 2465. 1989, Sigma). The raw MS and MS/MS data were used in database searches using the MASCOT search engine (Matrix Science, London, UK, http://www.matrixscience.com/) and UniProt (http://www.uniprot.org/) with a mass tolerance of 0.2 Da.

Western blot analysis
---------------------

Western blotting was performed as described previously \[[@r19],[@r20],[@r21], [@r23],[@r24],[@r25], [@r28], [@r29]\]. Samples (30 MII oocytes or zygotes for PRDX1 detection and 50 MII oocytes or zygotes for PRDX-SO~2/3~ detection) were subjected to sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis. Each sample was treated with the same volume of 2 × SDS sample buffer (125 mM Tris-HCl (pH 6.8), 4% SDS, 0.02% BPB, 20% glycerol, and 10% 2-mercaptoethanol) before SDS-PAGE. Non-reduced samples were prepared without the 10% 2-mercaptoethanol \[[@r30]\]. Proteins were resolved in 12% running gels for 2 h and electrophoretically transferred to polyvinylidene difluoride (PVDF) membranes (GE Healthcare) for 1.5 h. The membrane was washed with phosphate-buffered saline (PBS), incubated in Block Ace (Dainippon-Pharm, Osaka, Japan) at RT for 1 h, washed twice with PBS containing 0.2% Tween 20 (PBST) for 10 min, and incubated at 4°C overnight with anti-PRDX1 antibody (1:100,000; Abcam, Cambridge, UK; ab41906), anti-PRDX-SO~2/3~ antibody (1:2,000; Abcam; ab16830), and anti-Actin antibody (1:10,000; Sigma; A5441) as a loading control. The membrane was washed in PBST, incubated with donkey anti-rabbit IgG-horseradish peroxidase (HRP) conjugate (1:200,000; Sigma; A0545) and donkey anti-goat IgG HRP conjugate (1:200,000; Millipore; AP180P) at RT for 1 h, washed three times with PBST for 10 min, and developed using ECL Prime Western Blotting detection reagent (GE Healthcare).

Immunocytochemistry of zygotes
------------------------------

The classification of pronuclear (PN) stages was performed according to previous studies \[[@r31]\], where the pronuclear morphology and hours post-insemination (hpi) were taken into consideration. The subcellular localization of PRDX1, PRDX-SO~2/3~, 5-methylcytosine (5mC), and 5hmC was determined by immunocytochemical analysis of zygotes, as described \[[@r19],[@r20],[@r21],[@r22], [@r24], [@r25], [@r32]\]. Embryos were fixed in 10% formaldehyde neutral buffer solution (Nakalai Tesque, Kyoto, Japan) at RT for 15 min and the zona pellucida was removed with acid Tyrode's solution. Samples were then washed three times in PBS containing 3% bovine serum albumin (PBS-BSA) and permeabilized with PBS-BSA containing 0.5% Triton X-100 (Nakalai Tesque) at RT for 15 min. For 5mC and 5hmC, the specimens were denatured with 4 N HCl at RT for 10 min and then neutralized with 40 mM Tris-HCl (pH 8.5) for 20 min. They were then incubated with anti-PRDX1 antibody (1:20,000), anti-PRDX-SO~2/3~ antibody (1:2,000; Abcam; ab16830), anti-5mC antibody (1:2,000; Calbiochem, Darmstadt, Germany; NA81), or anti-5hmC antibody (1:2,000; Active motif, Carlsbad, CA, USA; 39769) in PBS-BSA at 4°C overnight. After incubation, the samples were treated with Alexa Fluor 555-labeled donkey anti-rabbit IgG secondary antibody (1:2,000; Life Technologies, Carlsbad, CA, USA; A-21207) for anti-PRDX1, PRDX-SO~2/3~, and 5hmC antibodies, with an Alexa Fluor 488-labeled donkey anti-mouse IgG secondary antibody (1:2,000; Invitrogen; A21202) for detection of the 5mC antibody, all at RT for 1 h. PRDX1-, PRDX-SO~2/3~-, 5mC- and 5hmC-stained zygotes were each mounted into VECTASHIELD (Vector Laboratories, Burlingame, CA, USA) mounted on the slide glasses containing 3 µg/ml 4′ 6-diamidino-2-phenylindole (DAPI) (Invitrogen; D1306). Finally, the PRDX1-, PRDX-SO~2/3~-stained zygotes were imaged using a conventional upright microscope (Axioplan2, Carl Zeiss, Jene, Germany) equipped with a mercury lamp (HBO 100, Carl Zeiss), and digital CCD camera (AxioCamMRc5, Carl Zeiss). The 5mC-, 5hmC-, and PRDX-SO~2/3~-stained zygotes were imaged using a confocal laser-scanning microscope (LSM 800, Carl Zeiss) equipped with 40 × and 63 × silicon oil-immersion objectives (Carl Zeiss).

Immunocytochemistry of cumulus cells
------------------------------------

Cumulus cells obtained by *in vitro* fertilization were fixed in 4% PFA at RT for 15 min. Those cells were permeabilized with PBS-BSA containing 0.5% Triton X-100 at RT for 15 min and then incubated with anti-PRDX-SO~2/3~ antibody (1:2,000) in PBS-BSA at 4°C overnight. After incubation, the cells were treated with an Alexa Fluor 555 labeled donkey anti-rabbit IgG secondary antibody (1:2,000) for anti-PRDX-SO~2/3~ at RT for 1 h. Specimens were mounted on glass slides in VECTASHIELD mounting medium containing 3 µg/ml DAPI. Finally, the slides were imaged using a confocal laser-scanning microscope (LSM 800, Carl Zeiss) equipped with a 63 × silicon oil-immersion objective (Carl Zeiss).

Treatment of mouse zygotes with H~2~O~2~
----------------------------------------

Previously, it was shown that mouse zygotes treated with 200 µM H~2~O~2~ for 15 min results in the inhibition of cleavage and/or fragmentation \[[@r17]\]. To induce oxidative stress in early mouse zygotes, freshly fertilized oocytes at 1 hpi were incubated in KSOM including 10, 50, 100 or 200 µM H~2~O~2~ at 37°C under 5% CO~2~ in air for 5 h. For the control, the same protocol was used without H~2~O~2~. At 6 hpi, fertilized oocytes were washed with KSOM prior to further analysis. Preliminarily we determined the H~2~O~2~ concentration that did not affect embryonic survival and pronuclei formation in freshly fertilized oocytes at 6 hpi, which is approximately PN3 \[[@r31]\]. As shown in [Supplementary Table 1](#pdf_001){ref-type="supplementary-material"} (online only), the zygotes were able to form pronuclei in 100 µM H~2~O~2~-treatment at least until 6 hpi and maintained developmental ability to the 2-cell stage. In this study, we used 100 µM H~2~O~2~ as an optimal oxidative stress condition.

Statistical analysis
--------------------

For statistical analysis, we used StatView version 5.0 (SAS Institute, Cary, NC, USA) and performed the analysis of Chi-square distribution and nonparametric test (Mann-Whitney U test) with an α level of 0.05 to determine possible statistically significant differences.

Results {#s2}
=======

Identification of endogenous antioxidant enzymes that are abundantly present in mouse MII oocytes and zygotes
-------------------------------------------------------------------------------------------------------------

We tried to explore the most abundant antioxidant enzymes in mouse zygotes in order to investigate the mechanisms of reducing ROS. However, it is more demanding to collect a large number of zygotes for proteomics analysis than to collect MII oocytes. Here, we decided to use MII oocytes instead of zygotes for proteomic analysis because zygotic genome activation (ZGA) occurs from the late 1-cell to early 2-cell stages and maternal proteins are stored in oocytes until ZGA \[[@r33], [@r34]\]. First, we performed 2-DE using MII oocytes, and obtained the 2-DE gel photos ([Fig. 1 A](#fig_001){ref-type="fig"}Fig. 1.Proteins from mouse oocytes and zygotes as separated by 2-DE. (A) Representative 2-DE master gel from 600 MII oocytes. (B) Representative 2-DE gels from 600 MII oocytes and 600 zygotes. The original gel size was 16 × 16 × 0.1 cm. MW, molecular weight; pI: isoelectric point.). Next, we analyzed the 2-DE gel photos to construct a reference gel for comparing the protein spots ([Fig. 1A](#fig_001){ref-type="fig"}). As a result, 449 protein spots were commonly detected on the gels in the 3 to 11 pH range and 10--200 kDa range ([Fig. 1A](#fig_001){ref-type="fig"}), and 137 protein spots (64 protein species) were identified from these gels by MALDI-TOF/MS ([Supplementary Table 2](#pdf_001){ref-type="supplementary-material"}: online only). Furthermore, we examined changes in protein expression from MII oocytes to zygotes by comparing the 2-DE gels from 600 MII oocytes and 600 zygotes ([Fig. 1B](#fig_001){ref-type="fig"}). PRDX1 and PRDX2 were identified as the TRX system in MII oocytes and zygotes, and the expression levels of all identified proteins were hardly changed between the MII oocytes and the zygotes ([Table 1](#tbl_001){ref-type="table"}Table 1.The ranking of identified protein expression levels in mouse zygotes and [Supplementary Table 3](#pdf_001){ref-type="supplementary-material"}: online only). We detected PRDX1 and PRDX2 as the ninth and twenty-second highest expressing proteins, respectively, among the 64 proteins identified in the mouse zygotes ([Table 1](#tbl_001){ref-type="table"}). PRDX family members (PRDX1-4), which are mainly reduced by TRX, eliminate H~2~O~2~ in various cellular locations \[[@r35],[@r36],[@r37],[@r38]\], we focused on not only PRDX1 but also the function of all PRDX family members as reducers in this study.

Existence of oxidized PRDX1 in the pronuclei of zygotes
-------------------------------------------------------

To reveal the localization of PRDX1, we performed immunocytochemical analysis. PRDX1 signals were observed both in the cytoplasm and pronuclei of zygotes at PN5, although the signals were mostly observed in the cytoplasm at PN1-4 ([Fig. 2A](#fig_002){ref-type="fig"}Fig. 2.Localization of PRDX1 and the existence of oxidized PRDX1 in zygotes at pronuclear stages. (A) Immunostaining for localization of PRDX1 at pronuclear stages (PN) 1--5. Shown are representative images of zygotes stained with DAPI (blue) and anti-PRDX1 antibody (red). Key: ♂, male pronucleus; ♀, female pronucleus; PB, polar body; scale bars = 50 µm. (B) Reduced and non-reduced immunoblots for PRDX1 at pronuclear stages. The bands predicted as nonspecific signal or covalent complexes are indicated by \*. β-ACTIN was used as a loading control in immunoblot analyses. MW, molecular weight.). PRDX family proteins contain an N-terminal Cys that is selectively oxidized as a substitute for other proteins, and oxidized PRDX1-4 have a characteristic to form homodimers mediated by a disulfide bond \[[@r35],[@r36],[@r37],[@r38]\]. To examine whether PRDX1 acts as a reducer during pronuclear stages, we attempted to distinguish dimeric PRDX1 using non-reducing SDS-PAGE conditions which leave disulfide bonds intact \[[@r30], [@r39]\]. As a result, we detected PRDX1 signals at approximately 44 kDa, equivalent to the dimeric form, and no PRDX1 signals at approximately 22 kDa, equivalent to the monomeric form ([Fig. 2B](#fig_002){ref-type="fig"}). These results indicate that PRDX1 is oxidized during the pronuclear stages of zygotes.

Hyperoxidation of PRDX family members in pronuclear zygotes
-----------------------------------------------------------

PRDX family members, including PRDX1, are hyperoxidized by excessive H~2~O~2~ before being reduced by TRX \[[@r35],[@r36],[@r37],[@r38]\]. To investigate the profile of hyperoxidized PRDX family members in zygotes, we performed immunocytochemical and immunoblot analyses using anti-PRDX-SO~2/3~ antibody, which recognizes the hyperoxidized form of PRDX family members (PRDX1-4). Interestingly, the PRDX-SO~2/3~ signals were observed intensely in pronuclei throughout PN2-5 ([Fig. 3A](#fig_003){ref-type="fig"}Fig. 3.Localization of PRDX-SO~2/3~ in zygotes and somatic cells. (A) Immunostaining for localization of PRDX-SO~2/3~ at pronuclear stages (PN) 1--5. Shown are representative images of zygotes stained with DAPI (blue) and anti-PRDX-SO~2/3~ antibody (red). Key: ♂, male pronucleus; ♀, female pronucleus; PB, polar body; scale bars = 50 µm. (B) Reduced and non-reduced immunoblots for PRDX-SO~2/3~ at pronuclear stages. The bands predicted as nonspecific signal or covalent complexes are indicated by \*. β-ACTIN was used as a loading control in immunoblot analyses. MW, molecular weight. (C) Immunostaining for localization of PRDX-SO~2/3~ in cumulus cells. Shown are representative images of cumulus cells stained with DAPI (blue) and anti-PRDX-SO~2/3~ antibody (red). Scale bars = 10 µm.), although pronuclear PRDX1 signals were clearly observed only at PN5 ([Fig. 2A](#fig_002){ref-type="fig"}). Furthermore, hyperoxidized PRDX was detected as the dimeric form during pronuclear stages ([Fig. 3B](#fig_003){ref-type="fig"}). Our findings suggest that the other PRDX family members in addition to PRDX1 may play key roles as reducers in the pronuclei and cytoplasm of zygotes.

Next, to test whether the pronuclear accumulation of hyperoxidized PRDX is specific to zygotes compared with somatic cells, we performed immunocytochemical analysis using anti-PRDX- SO~2/3~ antibody in cumulus cells, which seem to be exposed to exogenous oxidative stress under the same condition as zygotes. PRDX-SO~2/3~ signals were not observed in the nuclei of cumulus cells ([Fig. 3C](#fig_003){ref-type="fig"}). Taken together, these results suggest the possibility of specific functions of PRDX family members as endogenous antioxidant enzymes in pronuclei of zygotes.

Accumulation of hyperoxidized PRDX in pronuclei of H~2~O~2~-treated zygotes and the dynamics of 5hmC in male pronuclei of H~2~O~2~-treated zygotes
--------------------------------------------------------------------------------------------------------------------------------------------------

Since one of the specific events occurring in the pronuclei of zygotes is active DNA demethylation of the male pronucleus \[[@r40], [@r41]\], the possibility of zygotic-specific functions of pronuclear PRDX family members led us to examine the involvement of PRDX in active DNA demethylation of the male pronuclei of zygotes. To address this under oxidative stress conditions by H~2~O~2~-treatment, we performed localization assays using antibodies to 5mC, 5hmC, and PRDX-SO~2/3~ in freshly fertilized oocytes at 6 hpi ([Fig. 4A](#fig_004){ref-type="fig"}Fig. 4.Hyperoxidation of PRDX and accumulation of 5hmC on the male genome induced by H~2~O~2~-treatment. (A) Schematic diagram of the experimental procedure. (B) Immunostaining images of PRDX-SO~2/3~ in untreated and H~2~O~2~-treated zygotes. Key: ♂, male pronucleus; ♀, female pronucleus. PB, polar body; scale bar = 50 µm. (C) Quantification of the ratio of PRDX-SO~2/3~ intensities in untreated and H~2~O~2~-treated zygotes at 6 hpi. Red bars indicate the median values. The number of zygotes is 20 for each group. (D) Immunostaining images of 5mC (green) and 5hmC (red) in untreated and H~2~O~2~-treated zygotes. Key: ♂, male pronucleus; ♀, female pronucleus. Scale bar = 20 µm. (E) and (F) Quantification of the ratio of 5mC and 5hmC intensities in the pronucleus of untreated and H~2~O~2~-treated zygotes at 6 hpi. Red bars indicate the median values. The number of zygotes is 15 for each group.), which corresponds to approximately PN3 \[[@r31]\]. A large amount of PRDX-SO~2/3~ was significantly observed in the male and female pronuclei of H~2~O~2~-treated zygotes compared to those of untreated ones (male pronucleus: P = 0.0038, female pronucleus: P = 0.0020), although PRDX-SO~2/3~ was clearly present in the pronuclei and cytoplasm of both treated and untreated zygotes ([Fig. 4B, 4C](#fig_004){ref-type="fig"}, and [Supplementary Fig. 1A](#pdf_001){ref-type="supplementary-material"}: online only). The observation that hyperoxidized PRDX predominantly accumulated in the pronuclei of zygotes was confirmed under the oxidative damage conditions induced by H~2~O~2~ treatment, indicating that the PRDX functions as endogenous antioxidant enzymes in the pronuclei of zygotes. Next, we found that there was a significant decrease in the level of 5hmC in male pronuclei of H~2~O~2~-treated zygotes (P = 0.002; [Fig. 4D, 4F](#fig_004){ref-type="fig"}, and [Supplementary Fig. 1B](#pdf_001){ref-type="supplementary-material"}), indicating that the accumulation of hyperoxidized PRDX in the male pronuclei of zygotes correlates with a decrease in the observed amount of 5hmC, an oxidation product of 5mC by Tet methylcytosine dioxygenase 3 (Tet3). These results collectively suggest that endogenous PRDX is involved in both the antioxidant mechanisms and epigenetic reprogramming of freshly fertilized oocytes.

Discussion {#s3}
==========

In this study, we identified PRDX1 and PRDX2 as abundantly expressed endogenous antioxidants in MII oocytes and zygotes ([Table 1](#tbl_001){ref-type="table"} and [Supplementary Table 3](#pdf_001){ref-type="supplementary-material"}). Moreover, we also identified 9 reductases, which catalyze NAD (P) ^+^ to NAD (P) H, and glutathione S-transferase A4 (GSTA4) as the GSH system, although these proteins do not directly reduce ROS ([Table 1](#tbl_001){ref-type="table"} and [Supplementary Table 2](#pdf_001){ref-type="supplementary-material"}). In total, 12 redox proteins (19% of the identified 64 proteins) were abundantly expressed in MII oocytes and zygotes ([Table 1](#tbl_001){ref-type="table"} and [Supplementary Table 3](#pdf_001){ref-type="supplementary-material"}). In a previous proteomics analysis, 7,349 proteins were identified from 28 mouse tissues, and various antioxidants such as the TRX system, GSH system, and SOD are included in the 100 most abundant proteins in those tissues \[[@r42]\]. In particular, PRDX1 is included in the 100 most abundant proteins in 20 of these tissues \[[@r42]\]. On the other hand, PRDX2 is included in the 100 most abundant proteins in only 2 tissues, and the proteins of GSH system that directly eliminate H~2~O~2~, such as GPX, are not included in the 100 most abundant proteins in any tissues, while 7 types of GST are included in the 100 most abundant from 1-9 tissues \[[@r42]\]. In addition, SOD1 or SOD2 are included in the 100 most abundant proteins in 19 tissues \[[@r42]\]. According to another proteomics analysis using zygotes, SOD1 is indicated as the most abundant antioxidant in the identified proteins \[[@r43]\]. However, regarding the antioxidant enzymes involved in eliminating H~2~O~2~, PRDX1 is the most abundant antioxidant \[[@r43]\], which is in good agreement with our data. Thus, our results and these previous reports strongly support that PRDX1 is abundantly expressed as an antioxidant enzyme eliminating H~2~O~2~ in a wide range of cells, including MII oocytes and zygotes. PRDX1 and SOD1 may mainly play a role in eliminating H~2~O~2~ and superoxide, respectively, in various cells. Not only PRDX1 and PRDX2 identified by our investigation but also all isoforms of the PRDX family (PRDX1-6) in MII oocytes and zygotes are identified in the previous report \[[@r43]\]. Furthermore, another proteomics analysis indicates that PRDX2 and PRDX4 are highly expressed proteins in porcine fibroblast cell nuclei incubated in extracts from MII oocytes, as compared with those in germinal vesicle (GV) oocytes or fibroblast cells \[[@r44]\]. Taken together, PRDX family members might be actively involved in eliminating H~2~O~2~ in fertilized oocytes and early embryos as well as somatic cells.

As shown in [Fig. 3A and 3C](#fig_003){ref-type="fig"}, our results suggest the possibility of specific functions for of PRDX family members as endogenous antioxidant enzymes in pronuclei of zygotes. In the previous reports, as for the antioxidant enzyme in nuclei of cells, nucleoredoxin (NRX) has been discovered by its overexpression \[[@r45], [@r46]\]. In fact, it has been reported that endogenous NRX exists predominantly in the cytoplasm of cultured cells by cell fractionation \[[@r47]\]. While the endogenous antioxidant enzymes actively existing in the nucleus has been uncertain, our data provide the first evidence that PRDX1 and other PRDX family members are pronuclear-localized antioxidant enzymes in zygotes. The pronuclear PRDX1 signals were observed at PN5 compared to other stages while PRDX1 functions before fertilization ([Fig. 2B](#fig_002){ref-type="fig"}). PN5 (largely during 10--12 hpi) zygotes are mostly in G2 phase \[[@r31], [@r33]\], and according to the previous report, the H~2~O~2~-treated zygotes in G1 phase (at 7 hpi) are shown to significantly delay their entry to G2/M phase and to decrease the ratio of embryos that develop to the 2-cell stage \[[@r48], [@r49]\]. Thus, not to delay G2/M checkpoint activation induced by H~2~O~2~ as much as possible, PRDX1 might play a role in eliminating H~2~O~2~ in the pronucleus with the other PRDX family for normal embryo development. However, *Prdx1* knockout mice are viable, although they have a shortened lifespan due to the development of severe haemolytic anemia and several malignant cancers beginning at about 9 months of age, and the DNA damage is significantly elevated in some murine tissues \[[@r50], [@r51]\]. In addition, *Prdx2* knockout mice have been reported to show similar phenotypes \[[@r52]\]. Thus, some PRDX proteins might compensate for eliminating H~2~O~2~ even though one kind of *Prdx* is lacking in an early embryonic development. While pronuclear PRDX1 was observed at a later pronuclear stage, hyperoxidized PRDX signals were observed in pronuclei from PN2 ([Fig. 2A and 3A](#fig_002){ref-type="fig"}). The other report shows that PRDX2 is not observed in pronuclei at PN3 \[[@r53]\]. Therefore, pronuclear hyperoxidized PRDX proteins around PN3 may be any of PRDX3-6. On the other hand, we could not observe any hyperoxidized PRDX signals in the nuclei of cumulus cells despite their exposure to the same stress environment as the zygotes ([Fig. 3C](#fig_003){ref-type="fig"}). Therefore, PRDX proteins appear to specifically function as endogenous antioxidant enzymes in pronuclei of zygotes.

We also observed that treatment of zygotes at the pronuclear stage with H~2~O~2~ impaired the generation of 5hmC on the male genome but showed no significant effect on the existing 5mC ([Fig. 4D, 4E, 4F](#fig_004){ref-type="fig"}, and [Supplementary Fig. 1B](#pdf_001){ref-type="supplementary-material"}). Since spermatic 5mC is removed independently of Tet3, and then *de novo* 5mC by DNA methyltransferases (DNMTs) is converted to 5hmC by Tet3 in zygotes \[[@r54]\], we speculate that the activity of Tet3 and DNMTs might be depressed under the oxidative stress induced by the H~2~O~2~-treatment. Indeed, H~2~O~2~ exposure results in lowered Tet3 activity in cultured mammalian cells \[[@r55]\]. As mentioned above, we found that PRDX proteins appear to specifically function as endogenous antioxidant enzymes in the pronuclei of zygotes. Taken together, our results suggest that epigenetic reprogramming might be regulated under ROS conditions moderated by PRDX-mediated antioxidant mechanisms during the maternal-to-zygotic transition (MZT). Correspondingly, the observation that preventing oxidative stress is important for epigenetic reprogramming, is shown in a recent report, in which treatment with the antioxidant, vitamin C after exposure to the HDAC inhibitor, trichostatin A, dramatically improves cloning efficiency in somatic cell nuclear transfer (SCNT) embryos \[[@r56]\]. Further studies are needed to elucidate how PRDX-mediated antioxidant mechanisms are involved in epigenetic reprogramming during MZT.
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